Patent · US Active

Prostaglandin derivatives

US8058467B2 · kind B2 · utility

8Cited by
10References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2011
Grant dateNov 15, 2011
Priority date
Expiry dateFeb 11, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.